TGF-β has a potent growth inhibitory effect on epithelial and lymphoid tissues at the early stage of tumor development, but it also becomes a pro-oncogenic factor that stimulates tumor cell growth and invasiveness at the later stage [9]. The gene discussed is TGFB1; the disease is neoplasm.